June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
AAV-mediated Long Term Rescue of Cone Function in the CNGA3-/-Nrl-/- Mice Following Intravitreal Injection
Author Affiliations & Notes
  • Yuxin Zhang
    Ophthalmology, University of Florida, Gainesville, FL
    Ophthalmology, First Affiliated Hospital, Nanjing Medical University, Nanjing, China
  • Wei Du
    Ophthalmology, University of Florida, Gainesville, FL
  • Ping Zhu
    Ophthalmology, University of Florida, Gainesville, FL
  • Jie Li
    Ophthalmology, University of Florida, Gainesville, FL
  • Wen-Tao Deng
    Ophthalmology, University of Florida, Gainesville, FL
  • Sanford L Boye
    Ophthalmology, University of Florida, Gainesville, FL
  • Xi-Qin Ding
    Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK
  • Shannon Elizabeth Boye
    Ophthalmology, University of Florida, Gainesville, FL
  • William W Hauswirth
    Ophthalmology, University of Florida, Gainesville, FL
  • Footnotes
    Commercial Relationships Yuxin Zhang, None; Wei Du, None; Ping Zhu, None; Jie Li, None; Wen-Tao Deng, None; Sanford Boye, UF (P); Xi-Qin Ding, None; Shannon Boye, None; William Hauswirth, AGTC (C), AGTC (F), AGTC (P)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 5468. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yuxin Zhang, Wei Du, Ping Zhu, Jie Li, Wen-Tao Deng, Sanford L Boye, Xi-Qin Ding, Shannon Elizabeth Boye, William W Hauswirth; AAV-mediated Long Term Rescue of Cone Function in the CNGA3-/-Nrl-/- Mice Following Intravitreal Injection. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):5468.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Deletion of neural retina leucine zipper in mice (Nrl−/−) results in the complete absence of rods and an all-cone retina. Nrl-/- mice lack a scotopic response and have enhanced photopic ERG amplitudes. Mutations in the gene encoding the alpha-subunit of the cone cyclic nucleotide-gated channel (CNGA3) cause loss of cone function in mammals and are associated with achromatopsia in humans. CNGA3-/-Nrl-/- mice have been bred in part to mimic the cone-rich central retina in human achromatopsia 2 with CNGA3 mutations. Here we tested whether mutant AAV8 (Y447, 733F) vector can persistently restore cone system function/structure following intravitreal injection in this model.

Methods: At postnatal day 14, one μl of AAV8 (Y447, 733)-IRBP/GNAT2-mCnga3 vector (1013 particles/ml) was injected intravitreally into one eye of each CNGA3-/-Nrl-/- mouse. The other eye was uninjected to serve as a control. Dark- and light-adapted ERGs were recorded at six months after either injection. Then treated and control eyes were harvested for immunohistochemical studies.

Results: At six months following intravitreal injection, rod-related scotopic ERG waveforms were recorded in either treated or untreated Cnga3/Nrl DKO eyes. At a flash intensity of 1.4 log cd.s/m2, the average b-wave amplitudes of cone-related photopic ERGs were 63.76±24.05 μV in treated CNGA3-/-Nrl-/- eyes, 12.35±5.733 μV in untreated CNGA3-/-Nrl-/- eyes, and 137.2 ± 25.94 μV in age-matched Nrl-/- control eyes. There were significant differences between them. Eyes with the best light-adapted ERG restoration showed similar cone opsin levels as Nrl-/- control eyes with abundant M- and S-opsins observed in the cone outer segments. In untreated eyes, both M- and S-cone opsins were absent. Optomotor testing showed improved cone-driven visual acuity and contrast sensitivity in the treated CNGA3-/-Nrl-/- eyes, compared with those in the untreated eyes.

Conclusions: Intravitreal delivery of mutant AAV can restore cone function and halt cone degeneration for at least six months in the CNGA3-/-Nrl-/- mice. These results serve as a baseline for studying the intravitreal injection-mediated gene replacement therapy for human achromatopsia.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×